The Leadership Team at Lucid Diagnostics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of its innovative diagnostic devices, EsoCheck and EsoGuard. This team ensures alignment across all departments, including clinical research, financial management, and market strategies, to drive the mission of improving early detection and diagnosis of Barrett's Esophagus.
View all